Arizona - August 2015 Archives

  PHOENIX -- A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology. “In most cancer clinical trials, information on side effects is collected by providers who have limited time with their patients and current patient questionnaires are limited in scope and depth," says the study's lead author Amylou Dueck, Ph.D., a biostatistician on Mayo Clinic’s Arizona campus. "PRO-CTCAE is a library of items for patients to directly report on the level of each of their symptoms, to enhance the reporting of side effects in cancer clinical trials which is normally based on information from providers. The study itself is unprecedented as more than 100 distinct questions about symptomatic adverse events were validated simultaneously." Researchers recruited more than 1,000 patients from nine clinical practices across the U.S., including seven cancer centers. These patients reflected the geographic, ethnic, racial and economic diversity in cancer clinical trials. Patients in the study also had a wide range of cancer types. MEDIA CONTACT: Jim McVeigh, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu

SCOTTSDALE, Ariz. – Pierre Noel, M.D., a bone marrow transplant surgeon at Mayo Clinic in Arizona, was recently named to the Atlantic Council, a prestigious think tank for international affairs. Dr. Noel will be a Nonresident Senior Fellow in the Brent Scowcroft Center on International Security. Dr. Noel is a professor of medicine and serves as the director of the Blood and Marrow Transplant Program. He is an adviser to the federal government on issues pertaining to medical support to counterterrorism operations. Dr. Noel joined Mayo in 1988 and left in 2000 to serve as the chief of hematology and a senior clinician for the National Institutes of Health Clinical Center in Bethesda, Maryland, and a consultant for the U.S. Homeland and National Security Council. He rejoined Mayo Clinic in 2010. MEDIA CONTACT: Jim McVeigh, Mayo Clinic Public Affairs, 507-284-5005,newsbureau@mayo.edu